Neuland Laboratories Limited (NSE:NEULANDLAB)
India · Delayed Price · Currency is INR 14,950
-117 (-0.78%)
Apr 23, 2026, 3:30 PM IST
Neuland Laboratories Market Cap
Neuland Laboratories has a market cap or net worth of 191.78 billion as of April 23, 2026. Its market cap has increased by 23.77% in one year.
Market Cap
191.78B
Enterprise Value
192.74B
Revenue
15.75B
Ranking
n/a
PE Ratio
107.06
Stock Price
14,950.00
Market Cap Chart
Since December 18, 2000, Neuland Laboratories's market cap has increased from 335.14M to 191.78B, an increase of 57,125.04%. That is a compound annual growth rate of 28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 193.46B | -0.73% |
| Dec 31, 2025 | 194.89B | 10.65% |
| Dec 31, 2024 | 176.13B | 159.63% |
| Dec 29, 2023 | 67.84B | 216.90% |
| Dec 30, 2022 | 21.41B | 7.77% |
| Dec 31, 2021 | 19.86B | 41.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ajanta Pharma | 347.09B |
| Emcure Pharmaceuticals | 303.53B |
| Gland Pharma | 296.66B |
| Wockhardt | 234.17B |
| Piramal Pharma | 204.24B |
| Eris Lifesciences | 193.36B |
| NATCO Pharma | 191.83B |
| Alembic Pharmaceuticals | 151.11B |